Spotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic review.

MLA

Kedia, Rohit, et al. “Spotlight on Empagliflozin/Metformin Fixed-Dose Combination for the Treatment of Type 2 Diabetes: A Systematic Review.” Patient Preference and Adherence, vol. 10, Sept. 2016, pp. 1999–2006. EBSCOhost, https://doi.org/10.2147/PPA.S85748.

APA

Kedia, R., Kulkarni, S., Ross, M., & Shivaswamy, V. (2016). Spotlight on empagliflozin/metformin fixed-dose combination for the treatment of type 2 diabetes: a systematic review. Patient Preference and Adherence, 10, 1999–2006. https://doi.org/10.2147/PPA.S85748

Chicago

Kedia, Rohit, Supriya Kulkarni, Meredith Ross, and Vijay Shivaswamy. 2016. “Spotlight on Empagliflozin/Metformin Fixed-Dose Combination for the Treatment of Type 2 Diabetes: A Systematic Review.” Patient Preference and Adherence 10 (September): 1999–2006. doi:10.2147/PPA.S85748.